Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 205.63
+1.94 (0.95%)
Sep 16, 2025, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 270.47 billion as of September 16, 2025. Its market cap has increased by 11.78% in one year.
Market Cap
270.47B
Enterprise Value
314.95B
Revenue
91.34B
Ranking
n/a
PE Ratio
277.93
Stock Price
205.63
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 270.47B, an increase of 19.29%. That is a compound annual growth rate of 6.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 273.05B | -22.65% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,864.13B |
| Divi's Laboratories | 1,619.23B |
| Cipla | 1,259.29B |
| Apollo Hospitals Enterprise | 1,123.89B |
| Mankind Pharma | 1,060.71B |
| Zydus Lifesciences | 1,040.95B |
| Fortis Healthcare | 729.78B |
| Alkem Laboratories | 657.97B |